Skip to main content
Infection and Immunity logoLink to Infection and Immunity
. 1983 Jul;41(1):352–357. doi: 10.1128/iai.41.1.352-357.1983

Rash produced by mouse cytomegalovirus.

K T Chong, C A Mims
PMCID: PMC264785  PMID: 6305843

Abstract

A striking rash was produced in mice 4 days after intravenous injection of large doses of murine cytomegalovirus. Routine histology showed cell infiltration, vascular damage, and hemorrhage. Immunofluourescent staining showed dermal but not epidermal infection, and this appeared to be initiated after the localization in small blood vessels of circulating virus or of virus-containing leukocytes. The rash was accompanied by a high level of complement-requiring neutralizing antibodies in the serum and extensive deposition of immune complexes in the renal glomeruli containing immunoglobulin G, immunoglobulin M, and complement. When mice were depleted of complement by cobra venom factor, when antibody responses were reduced by cyclophosphamide treatment, or when a prostaglandin inhibitor (indomethacin) was given, the rash was much less severe. The role of direct viral damage and inflammatory and immune responses in the genesis of the lesions is discussed.

Full text

PDF
352

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Araullo-Cruz T. P., Ho M., Armstrong J. A. Protective effect of early serum from mice after cytomegalovirus infection. Infect Immun. 1978 Sep;21(3):840–842. doi: 10.1128/iai.21.3.840-842.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Campbell D. A., Piercey J. R., Shnitka T. K., Goldsand G., Devine R. D., Weinstein W. M. Cytomegalovirus-associated gastric ulcer. Gastroenterology. 1977 Mar;72(3):533–535. [PubMed] [Google Scholar]
  3. Chalmer J. E., Mackenzie J. S., Stanley N. F. Resistance to murine cytomegalovirus linked to the major histocompatibility complex of the mouse. J Gen Virol. 1977 Oct;37(1):107–114. doi: 10.1099/0022-1317-37-1-107. [DOI] [PubMed] [Google Scholar]
  4. Chong K. T., Mims C. A. Delayed hypersensitivity to murine cytomegalovirus and its depression during pregnancy. Infect Immun. 1982 Jul;37(1):54–59. doi: 10.1128/iai.37.1.54-59.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Chong K. T., Mims C. A. Murine cytomegalovirus particle types in relation to sources of virus and pathogenicity. J Gen Virol. 1981 Dec;57(Pt 2):415–419. doi: 10.1099/0022-1317-57-2-415. [DOI] [PubMed] [Google Scholar]
  6. Diethelm A. G., Gore I., Ch'ien L. T., Sterling W. A., Morgan J. M. Gastrointestinal hemorrhage secondary to cytomegalovirus after renal transplantation. A case report and review of the problem. Am J Surg. 1976 Mar;131(3):371–374. doi: 10.1016/0002-9610(76)90136-7. [DOI] [PubMed] [Google Scholar]
  7. Henson D. Cytomegalovirus inclusion bodies in the gastrointestinal tract. Arch Pathol. 1972 Jun;93(6):477–482. [PubMed] [Google Scholar]
  8. Hudson J. B. The murine cytomegalovirus as a model for the study of viral pathogenesis and persistent infections. Arch Virol. 1979;62(1):1–29. doi: 10.1007/BF01314900. [DOI] [PubMed] [Google Scholar]
  9. Lussier G. Glomerulonephritis caused by murine cytomegalovirus. Potentiation by antithymocyte serum. Vet Pathol. 1976;13(2):123–130. doi: 10.1177/030098587601300206. [DOI] [PubMed] [Google Scholar]
  10. MANNINI A., MEDEARIS D. N., Jr Mouse salivary gland virus infections. Am J Hyg. 1961 May;73:329–343. doi: 10.1093/oxfordjournals.aje.a120192. [DOI] [PubMed] [Google Scholar]
  11. Mims C. A., Gould J. Infection of salivary glands, kidneys, adrenals, ovaries and epithelia by murine cytomegalovirus. J Med Microbiol. 1979 Feb;12(1):113–122. doi: 10.1099/00222615-12-1-113. [DOI] [PubMed] [Google Scholar]
  12. Mims C. A. Pathogenesis of rashes in virus diseases. Bacteriol Rev. 1966 Dec;30(4):739–760. doi: 10.1128/br.30.4.739-760.1966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Mims C. A. The response of mice to the intravenous injection of cowpox virus. Br J Exp Pathol. 1968 Feb;49(1):24–32. [PMC free article] [PubMed] [Google Scholar]
  14. Minars N., Silverman J. F., Escobar M. R., Martinez A. J. Fatal cytomegalic inclusion disease. Associated skin manifestations in a renal transplant patient. Arch Dermatol. 1977 Nov;113(11):1569–1571. doi: 10.1001/archderm.113.11.1569. [DOI] [PubMed] [Google Scholar]
  15. Olding L. B., Kingsbury D. T., Oldstone M. B. Pathogenesis of cytomegalovirus infection. Distribution of viral products, immune complexes and autoimmunity during latent murine infection. J Gen Virol. 1976 Nov;33(2):267–280. doi: 10.1099/0022-1317-33-2-267. [DOI] [PubMed] [Google Scholar]
  16. POWELL R. D., WARNER N. E., LEVINE R. S., KIRSNER J. B. Cytomegalic inclusion disease and ulcerative colitis; report of a case in a young adult. Am J Med. 1961 Feb;30:334–340. doi: 10.1016/0002-9343(61)90105-x. [DOI] [PubMed] [Google Scholar]
  17. Selgrade M. K., Osborn J. E. Role of macrophages in resistance to murine cytomegalovirus. Infect Immun. 1974 Dec;10(6):1383–1390. doi: 10.1128/iai.10.6.1383-1390.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Stagno S., Volanakis J. E., Reynolds D. W., Stroud R., Alford C. A. Immune complexes in congenital and natal cytomegalovirus infections of man. J Clin Invest. 1977 Oct;60(4):838–845. doi: 10.1172/JCI108838. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Starr S. E., Allison A. C. Role of T lymphocytes in recovery from murine cytomegalovirus infection. Infect Immun. 1977 Aug;17(2):458–462. doi: 10.1128/iai.17.2.458-462.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Wu B. C., Ho M. Characteristics of infection of B and T lymphocytes from mice after inoculation with cytomegalovirus. Infect Immun. 1979 Jun;24(3):856–864. doi: 10.1128/iai.24.3.856-864.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES